147 related articles for article (PubMed ID: 15671934)
1. Crohn's disease over 20 years after diagnosis in a referral population.
Etienney I; Bouhnik Y; Gendre JP; Lémann M; Cosnes J; Matuchansky C; Beaugerie L; Modigliani R; Rambaud JC
Gastroenterol Clin Biol; 2004 Dec; 28(12):1233-9. PubMed ID: 15671934
[TBL] [Abstract][Full Text] [Related]
2. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study.
Fumery M; Pariente B; Sarter H; Savoye G; Spyckerelle C; Djeddi D; Mouterde O; Bouguen G; Ley D; Peneau A; Dupas JL; Turck D; Gower-Rousseau C;
Dig Liver Dis; 2019 Apr; 51(4):496-502. PubMed ID: 30611597
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
Oren R; Moshkowitz M; Odes S; Becker S; Keter D; Pomeranz I; Shirin H; Reisfeld I; Broide E; Lavy A; Fich A; Eliakim R; Patz J; Villa Y; Arber N; Gilat T
Am J Gastroenterol; 1997 Dec; 92(12):2203-9. PubMed ID: 9399753
[TBL] [Abstract][Full Text] [Related]
7. Conventional therapy for Crohn's disease.
Büning C; Lochs H
World J Gastroenterol; 2006 Aug; 12(30):4794-806. PubMed ID: 16937460
[TBL] [Abstract][Full Text] [Related]
8. Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.
Fumery M; Pariente B; Sarter H; Charpentier C; Armengol Debeir L; Dupas JL; Coevoet H; Peyrin-Biroulet L; dʼAgay L; Gower-Rousseau C; Savoye G;
Inflamm Bowel Dis; 2016 Jul; 22(7):1698-707. PubMed ID: 27206018
[TBL] [Abstract][Full Text] [Related]
9. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
10. A risk score system to timely manage treatment in Crohn's disease: a cohort study.
Pallotta N; Vincoli G; Pezzotti P; Giovannone M; Gigliozzi A; Badiali D; Vernia P; Corazziari ES
BMC Gastroenterol; 2018 Nov; 18(1):164. PubMed ID: 30400823
[TBL] [Abstract][Full Text] [Related]
11. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
12. Conventional treatment of Crohn's disease: objectives and outcomes.
Rutgeerts PJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S2-8. PubMed ID: 11380039
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease of the esophagus: clinical features and outcomes.
Decker GA; Loftus EV; Pasha TM; Tremaine WJ; Sandborn WJ
Inflamm Bowel Dis; 2001 May; 7(2):113-9. PubMed ID: 11383583
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
[TBL] [Abstract][Full Text] [Related]
15. Review article: maintenance treatment of Crohn's disease.
Biancone L; Tosti C; Fina D; Fantini M; De Nigris F; Geremia A; Pallone F
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():31-7. PubMed ID: 12786610
[TBL] [Abstract][Full Text] [Related]
16. Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.
Jakobsen C; Munkholm P; Paerregaard A; Wewer V
Inflamm Bowel Dis; 2011 Aug; 17(8):1731-40. PubMed ID: 21744428
[TBL] [Abstract][Full Text] [Related]
17. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
Brookes MJ; Green JR
Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787
[TBL] [Abstract][Full Text] [Related]
19. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
20. [Follow up of Crohn's disease under therapy with hydro-MRI].
Ganten M; Encke J; Flosdorff P; Grüber-Hoffmann B; Erb G; Hansmann J
Radiologe; 2003 Jan; 43(1):26-33. PubMed ID: 12552372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
